InterventionsHumans

Long-Term Impact of GLP-1 Receptor Agonists on Cardiovascular Outcomes in Patients Treated with Hematopoietic Stem Cell Transplantation: A Propensity-Score Matched Analysis

AHA Scientific Sessions 2025 Abstract

The paper

Yeo YH, Ong TE, Wong HKK et al.

AHA Scientific Sessions 2025 Abstract · 3 Nov 2025

Presented at AHA Scientific Sessions 2025 · Abstract 4370898

doi.org/10.1161/circ.152.suppl_3.4370898

GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes, Obesity & Metabolism · 4 Oct 2026
Donor TET2 variant linked to lower stem cell transplant survival
International Journal of Molecular Sciences · 4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes & Vascular Disease Research · 4 Oct 2026
GLP-1 receptor agonists link to lower stroke and Alzheimer risk
Neurology Genetics · 4 Oct 2026